CD8A and severe acute respiratory syndrome: Several studies have reported that SARS-CoV-specific CD8 CTLs substantially protected against SARS-CoV infection in mice [25] and were increased in mice that were vaccinated with SARS-CoV S DNA as the vaccine antigen [26].